GeneDx Holdings Corp. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
GeneDx Holdings Corp. (WGS) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.43 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-03
- GeneDx Holdings Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 2.43M shares, a 254.84% increase year-over-year.
- GeneDx Holdings Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.56M shares, a 8.40% decline year-over-year.
- GeneDx Holdings Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 2.58M shares, a 18.45% decline year-over-year.
- GeneDx Holdings Corp. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 683.59K shares, a 78.99% decline year-over-year.
- GeneDx Holdings Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 2.41M shares, a 16.94% decline from fiscal 2024.
- GeneDx Holdings Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 2.90M shares, a 16.54% decline from fiscal 2023.
- GeneDx Holdings Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.47M shares, a 19.87% increase from fiscal 2022.
- GeneDx Holdings Corp. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.90M shares, a 96.22% decline from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2.43M shares 10-Q · filed 2026-08-03 | 2.43M shares 10-Q · filed 2026-08-03 | ||||
| 2026-03-31 | 2.56M shares 10-Q · filed 2026-05-04 | |||||
| 2025-12-31 | 2.41M shares 10-K · filed 2026-02-23 | |||||
| 2025-09-30 | 2.58M shares 10-Q · filed 2025-10-28 | 2.58M shares 10-Q · filed 2025-10-28 | ||||
| 2025-06-30 | 683.59K shares 10-Q · filed 2026-08-03 | 683.59K shares 10-Q · filed 2026-08-03 | ||||
| 2025-03-31 | 2.79M shares 10-Q · filed 2026-05-04 | |||||
| 2024-12-31 | 2.90M shares 10-K · filed 2026-02-23 | |||||
| 2024-09-30 | 3.17M shares 10-Q · filed 2025-10-28 | 3.17M shares 10-Q · filed 2025-10-28 | ||||
| 2024-06-30 | 3.25M shares 10-Q · filed 2025-07-29 | 3.25M shares 10-Q · filed 2025-07-29 | ||||
| 2024-03-31 | 4.05M shares 10-Q · filed 2025-04-30 | |||||
| 2023-12-31 | 3.47M shares 10-K · filed 2026-02-23 | |||||
| 2023-09-30 | 2.99M shares 10-Q · filed 2024-10-29 | |||||
| 2023-06-30 | 3.84M shares 10-Q · filed 2023-08-08 | 3.84M shares 10-Q · filed 2024-07-30 | ||||
| 2023-03-31 | 3.22M shares 10-Q · filed 2024-04-29 | |||||
| 2022-12-31 | 2.90M shares 10-K · filed 2024-02-23 | 95.60M shares 10-K · filed 2023-03-16 | ||||
| 2022-09-30 | 97.11M shares 10-Q · filed 2022-11-14 | 2.94M shares 10-Q · filed 2023-11-03 | ||||
| 2022-06-30 | 2.97M shares 10-Q · filed 2023-08-08 | 97.86M shares 10-Q · filed 2022-08-15 | ||||
| 2022-03-31 | 2.49M shares 10-Q · filed 2023-05-09 | 82.03M shares 10-Q · filed 2022-05-12 | ||||
| 2021-12-31 | 76.54M shares 10-K · filed 2023-03-16 | |||||
| 2021-09-30 | 38.33M shares 10-Q · filed 2022-11-14 | 67.17M shares 10-Q · filed 2021-11-15 | ||||
| 2021-06-30 | 200.44M shares 10-Q · filed 2022-08-15 | |||||
| 2021-03-31 | 201.14M shares 10-Q · filed 2022-05-12 | |||||
| 2020-12-31 | 189.96M shares 10-K · filed 2023-03-16 | |||||
| 2020-09-30 | 12.80M shares 10-Q · filed 2021-11-15 | 12.77M shares 10-Q · filed 2021-11-15 | ||||
| 2019-12-31 | 143.79M shares 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |